Search
Search
The need for faster results and better outcomes in disease research has resulted in a migration from traditional molecular biology techniques such as Sanger sequencing, PCR, and culture-based assays to targeted microbial species profiling and pathogen identification using next-generation sequencing (NGS).
The Ion Torrent and Ion AmpliSeq next-generation sequencing (NGS) technologies offer multiple solutions with advantages for clinical researchers studying infectious diseases and other microbial application areas to facilitate rapid and accurate sequencing of microbes.
Ion AmpliSeq technologies and sequencing on Ion Torrent platforms use a targeted approach to NGS, and have been pivotal in providing rapid research results, ranging from microbial whole genome sequencing in metagenomics to microbiome profiling, health research, infectious disease research, and pathogen identification. It also supports the analysis of archived samples for disease surveillance research and the studies focused on discovery of mutations that may be associated with antibiotic resistance.
Dr. Jennifer Dien Bard discusses her experience using an automated targeted NGS method to rapidly detect and identify bacteria and fungi directly from specimens.
When navigating through the complexities of infectious disease and microbiology research, you need a solution that is both flexible and rapid for analyzing microbes of interest. Ion AmpliSeq technology can help. It is globally used as an amplicon-based enrichment method for targeted NGS. Clinical researchers worldwide choose Ion AmpliSeq technology for fast, simple, and scalable NGS solutions.
Contact an NGS sales specialist to learn more about Ion AmpliSeq panels for infectious disease and microbiology research.
For Research Use Only. Not for use in diagnostic procedures.
PMR-000322